Author:
Shi Guo-Xian,Zhao Zi-He,Yang Xiao-Yan,Lin Mu,Chen Zhou-Xue
Funder
Science and Technology Planning Project of Guizhou Province
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference30 articles.
1. Progress in the individualized treatment of clopidogrel under the guidance of polymorphism of CYP2C19 gene;Li;Advances Cardiovascular Dis,2015
2. CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: a systematic review and meta-analysis;Niu;J Huazhong Univ Sci Technolog Med Sci,2015
3. Clopidogrel pharmacokinetics in Malaysian population groups: the impact of inter-ethnic variability;Zakaria;Pharmaceuticals (Basel),2018
4. Research progress on the clinical prevention and treatment of clopidogrel resistance;Li;Chin J Geriatric Heart Brain Vessel Dis,2015
5. Clinical outcomes of CYP2C19 genotype-guided antiplatelet therapy: existing evidence and future directions;Klein;Pharmacogenomics,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献